Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.62 |
| ▸ | RAD52 | P43351 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.45 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.45 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6034709 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL18140111 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL8751921 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL9437256 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL18140142 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL18140311 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL6128331 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL18139769 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL7588972 | 1.00 | NAAA (0.62) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL6116070 | 0.98 | NAAA (0.60) | NAAARAD52NPSR1DGKAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240398674-A1 | PERSONAL CLEANSING COMPOSITIONS WITH SURFACTANTS FOR INCREASED FOAM PERFORMANCE | ECOLAB USA INC. | 2024-12-05 | — | — | US | claimed |
| EP-4240317-A1 | PERSONAL CLEANSING COMPOSITIONS WITH SURFACTANTS FOR INCREASED FOAM PERFORMANCE | Ecolab USA Inc. (US) | 2023-09-13 | — | — | EP | claimed |
| WO-2023047023-A1 | PREPARATION OF A SULPHATED-SURFACTANT-FREE COMPOSITION | COATEX (FR) | 2023-03-30 | — | — | WO | claimed |
| WO-2022099114-A9 | PERSONAL CLEANSING COMPOSITIONS WITH SURFACTANTS FOR INCREASED FOAM PERFORMANCE | ECOLAB USA INC. (US) | 2022-09-22 | — | — | WO | claimed |
| WO-2022099114-A1 | PERSONAL CLEANSING COMPOSITIONS WITH SURFACTANTS FOR INCREASED FOAM PERFORMANCE | ECOLAB USA INC. (US) | 2022-05-12 | — | — | WO | claimed |
| US-20220142879-A1 | PERSONAL CLEANSING COMPOSITIONS WITH SURFACTANTS FOR INCREASED FOAM PERFORMANCE | ECOLAB USA INC. | 2022-05-12 | — | — | US | claimed |
| EP-3525753-B1 | HAIR COSMETIC COMPOSITIONS CONTAINING THIOL-BASED COMPOUNDS AND METHODS FOR CLEANSING AND TREATING HAIR | OREAL (FR) | 2022-04-13 | — | — | EP | claimed |
| EP-3524981-B1 | UNMASKING ENDOTOXINS IN SOLUTION | HYGLOS INVEST GMBH (DE) | 2021-03-03 | — | — | EP | claimed |
| EP-3367095-B1 | UNMASKING ENDOTOXINS IN SOLUTION | HYGLOS INVEST GMBH (DE) | 2020-11-18 | — | — | EP | claimed |
| CN-107496260-A | A kind of complexing agent containing Tea Polyphenols and preparation method thereof | 点铂医疗科技（常州）有限公司 | 2017-12-22 | — | — | CN | claimed |
| US-6559110-B1 | Synthetic detergent (syndet) bar soap composition useful for washing and cleaning hands and other body parts for preventing the risk of infections caused by microorganisms | MICROCIDE, INC. | 2003-05-06 | — | — | US | claimed |
| WO-2001023517-A1 | CLEANSER THAT IS GENTLE TO HUMAN SKIN | SHAKLEE CORPORATION (US) | 2001-04-05 | — | — | WO | claimed |
| EP-0925777-B1 | Cosmetic and/or dermatologic composition containing powdery ascorbic acid | OREAL (FR) | 2001-01-03 | — | — | EP | claimed |
| EP-0925777-A1 | Cosmetic and/or dermatologic composition containing powdery ascorbic acid | L'OREAL (FR) | 1999-06-30 | — | — | EP | claimed |
| EP-0703774-B1 | HIGH FOAMING ORAL COMPOSITION | COLGATE PALMOLIVE CO (US) | 1998-04-22 | — | — | EP | claimed |
| EP-0519942-B1 | COSMETIC CLEANSING AGENT | BEIERSDORF AG (DE) | 1994-10-05 | — | — | EP | claimed |
| EP-0442968-A4 | SELF-FOAMING OIL COMPOSITIONS AND PROCESS FOR MAKING AND USING SAME | — | 1993-06-30 | — | — | EP | claimed |
| WO-1991018968-A1 | SYNTHETIC FOAMS | NUCLEUS ENTERPRISE LIMITED (GB) | 1991-12-12 | — | — | WO | claimed |
| EP-0442968-A1 | SELF-FOAMING OIL COMPOSITIONS AND PROCESS FOR MAKING AND USING SAME. | IMAGINATIVE RES ASS (US) | 1991-08-28 | — | — | EP | claimed |
| WO-1990005774-A1 | SELF-FOAMING OIL COMPOSITIONS AND PROCESS FOR MAKING AND USING SAME | IMAGINATIVE RESEARCH ASSOCIATES, INC. (US) | 1990-05-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240398674-A1 | PERSONAL CLEANSING COMPOSITIONS WITH SURFACTANTS FOR INCREASED FOAM PERFORMANCE | AGPS, CUTA, SMURF1 | NAAA 175/4885RAD52 490/4885NPSR1 4108/4885 |
| US-20220142879-A1 | PERSONAL CLEANSING COMPOSITIONS WITH SURFACTANTS FOR INCREASED FOAM PERFORMANCE | AGPS, CUTA, SMURF1 | NAAA 175/4885RAD52 490/4885NPSR1 4108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.